← Russell 3000 cross-section

INSP Inspire Medical Systems, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-03, not restated
Healthcare

Scale

Market cap
$1.8bn
Revenue TTM
$899m
Net income TTM
$135m
Free cash flow
$117m
Composite score
63.7
Sector rank
#1698

Valuation

P / E
13.4
EV / EBITDA
20.8
EV / sales
1.7
FCF yield
6.48%
Earnings yield vs 10-yr
2.74pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
15.0%
EBITDA margin
7.9%
ROE
16.4%
ROIC
10.7%
Revenue growth
4.3%

Insider activity, last 90 days

Net open-market
$-0.06m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Results of Operations Revenue information by region is summarized as follows: Comparison of the Three Months Ended June 30, 2026 and 2025 • Revenue decreased $16.5 million, or 7.6%, to $200.6 million driven primarily by a decline in US revenue, partially offset by growth in International. Comparison of the Six Months Ended June 30, 2026 and 2025 • Revenue decreased $13.2 million, or 3.2%, to $405.2 million primarily due to a decline in U.S. revenue, partially offset by growth in International. The change was primarily driven by improved working capital, mainly in receivables and inventories. The change was primarily driven by lower proceeds from the sale or maturity of investments. …Inspire Medical Systems, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-03

Read the full passage →